Viewing StudyNCT00110149



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00110149
Status: TERMINATED
Last Update Posted: 2017-11-21
First Post: 2005-05-03

Brief Title: Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkins Lymphoma
Sponsor: Beth Israel Deaconess Medical Center
Organization: Beth Israel Deaconess Medical Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-05
Start Date Type: None
Primary Completion Date: 2012-05
Primary Completion Date Type: ACTUAL
Completion Date: 2015-03
Completion Date Type: ACTUAL
First Submit Date: 2005-05-03
First Submit QC Date: May 3 2005
Study First Post Date: 2005-05-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-11-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-10-19
Last Update Post Date: 2017-11-21
Last Update Post Date Type: ACTUAL